564 related articles for article (PubMed ID: 10894287)
1. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.
Whalen CC; Nsubuga P; Okwera A; Johnson JL; Hom DL; Michael NL; Mugerwa RD; Ellner JJ
AIDS; 2000 Jun; 14(9):1219-28. PubMed ID: 10894287
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA).
Antonucci G; Girardi E; Raviglione MC; Ippolito G
JAMA; 1995 Jul; 274(2):143-8. PubMed ID: 7596002
[TBL] [Abstract][Full Text] [Related]
3. Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy.
Hung CC; Chen MY; Hsiao CF; Hsieh SM; Sheng WH; Chang SC
AIDS; 2003 Dec; 17(18):2615-22. PubMed ID: 14685055
[TBL] [Abstract][Full Text] [Related]
4. Accelerated course of human immunodeficiency virus infection after tuberculosis.
Whalen C; Horsburgh CR; Hom D; Lahart C; Simberkoff M; Ellner J
Am J Respir Crit Care Med; 1995 Jan; 151(1):129-35. PubMed ID: 7812542
[TBL] [Abstract][Full Text] [Related]
5. Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy.
Schwander SK; Dietrich M; Mugyenyi P; Kityo C; Okwera A; Johnson J; Nsubuga P; Ruesch-Gerdes S; Whalen C
East Afr Med J; 1997 Sep; 74(9):543-8. PubMed ID: 9487427
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.
Komati S; Shaw PA; Stubbs N; Mathibedi MJ; Malan L; Sangweni P; Metcalf JA; Masur H; Hassim S
AIDS; 2010 Jul; 24(12):1849-55. PubMed ID: 20622529
[TBL] [Abstract][Full Text] [Related]
7. Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City. Implications for the expansion of the AIDS case definition.
Stoneburner R; Laroche E; Prevots R; Singh T; Blum S; Terry P; Reatrice S; Adler J
Arch Intern Med; 1992 Oct; 152(10):2033-7. PubMed ID: 1358042
[TBL] [Abstract][Full Text] [Related]
8. CD4 T lymphocyte count and the radiographic presentation of pulmonary tuberculosis. A study of the relationship between these factors in patients with human immunodeficiency virus infection.
Keiper MD; Beumont M; Elshami A; Langlotz CP; Miller WT
Chest; 1995 Jan; 107(1):74-80. PubMed ID: 7813316
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy improves survival among TB-HIV co-infected patients who have CD4+ T-cell count above 350cells/mm
Mutembo S; Mutanga JN; Musokotwane K; Alisheke L; Whalen CC
BMC Infect Dis; 2016 Oct; 16(1):572. PubMed ID: 27751168
[TBL] [Abstract][Full Text] [Related]
10. HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting.
Duncombe C; Kerr SJ; Ruxrungtham K; Dore GJ; Law MG; Emery S; Lange JM; Phanuphak P; Cooper DA
AIDS; 2005 Jan; 19(2):169-78. PubMed ID: 15668542
[TBL] [Abstract][Full Text] [Related]
11. Impact of tuberculosis on the course of HIV-infected patients with a high initial CD4 lymphocyte count.
Mañas E; Pulido F; Peña JM; Rubio R; Gonzalez-García J; Costa R; Pérez-Rodríguez E; Del Palacio A
Int J Tuberc Lung Dis; 2004 Apr; 8(4):451-7. PubMed ID: 15141738
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of the risk of tuberculosis among HIV-infected patients.
Guelar A; Gatell JM; Verdejo J; Podzamczer D; Lozano L; Aznar E; Miró JM; Mallolas J; Zamora L; González J
AIDS; 1993 Oct; 7(10):1345-9. PubMed ID: 8267907
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of tuberculosis and HIV disease progression.
Munsiff SS; Alpert PL; Gourevitch MN; Chang CJ; Klein RS
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):361-6. PubMed ID: 9833744
[TBL] [Abstract][Full Text] [Related]
14. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
Ledergerber B; Egger M; Erard V; Weber R; Hirschel B; Furrer H; Battegay M; Vernazza P; Bernasconi E; Opravil M; Kaufmann D; Sudre P; Francioli P; Telenti A
JAMA; 1999 Dec; 282(23):2220-6. PubMed ID: 10605973
[TBL] [Abstract][Full Text] [Related]
15. Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
Chêne G; Binquet C; Moreau JF; Neau D; Pellegrin I; Malvy D; Ceccaldi J; Lacoste D; Dabis F
AIDS; 1998 Dec; 12(17):2313-20. PubMed ID: 9863874
[TBL] [Abstract][Full Text] [Related]
16. Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis.
Uthman OA; Okwundu C; Gbenga K; Volmink J; Dowdy D; Zumla A; Nachega JB
Ann Intern Med; 2015 Jul; 163(1):32-9. PubMed ID: 26148280
[TBL] [Abstract][Full Text] [Related]
17. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.
Wood E; Hogg RS; Yip B; Harrigan PR; O'Shaughnessy MV; Montaner JS
Ann Intern Med; 2003 Nov; 139(10):810-6. PubMed ID: 14623618
[TBL] [Abstract][Full Text] [Related]
18. Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area.
Badri M; Ehrlich R; Wood R; Pulerwitz T; Maartens G
Int J Tuberc Lung Dis; 2001 Mar; 5(3):225-32. PubMed ID: 11326821
[TBL] [Abstract][Full Text] [Related]
19. Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil.
de Pinho AM; Santoro-Lopes G; Harrison LH; Schechter M
AIDS; 2001 Nov; 15(16):2129-35. PubMed ID: 11684932
[TBL] [Abstract][Full Text] [Related]
20. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
